PlainRecalls
FDA Drug Low Class III Terminated

Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03

Reported: May 26, 2021 Initiated: April 27, 2021 #D-0386-2021

Product Description

Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03

Reason for Recall

Failed Impurities/Degradation Specifications

Details

Recalling Firm
KVK-Tech, Inc.
Units Affected
17,096 bottles
Distribution
Distributed Nationwide in the USA
Location
Newtown, PA

Frequently Asked Questions

What product was recalled?
Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03. Recalled by KVK-Tech, Inc.. Units affected: 17,096 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on May 26, 2021. Severity: Low. Recall number: D-0386-2021.